Emmanouilidi, A., Fyffe, C. A., Ferro, R., Edling, C. E., Capone, E., Sestito, S., . . . Falasca, M. (2019). Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer. J Exp Clin Cancer Res.
Chicago Style CitationEmmanouilidi, Aikaterini, et al. "Preclinical Validation of 3-phosphoinositide-dependent Protein Kinase 1 Inhibition in Pancreatic Cancer." J Exp Clin Cancer Res 2019.
Cita MLAEmmanouilidi, Aikaterini, et al. "Preclinical Validation of 3-phosphoinositide-dependent Protein Kinase 1 Inhibition in Pancreatic Cancer." J Exp Clin Cancer Res 2019.
Atenció: Aquestes cites poden no estar 100% correctes.